SCHEMBL2191891

SCHEMBL2191891

CCCC(N)(CCC)CCCN(CC(=O)OCC)Cc1ccc(CN(Cc2nccn2C)Cc2nccn2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.46
TSHR P16473 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 4/20 0.33
POLB P06746 3/20 0.33
MEN1 O00255 3/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPC1 O15118 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LTA4H P09960 1/20 0.31
TBXAS1 P24557 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2192899 0.92 CXCR4 (0.47) CXCR4NPSR1LMNAKMT2APOLB
SCHEMBL2193663 0.89 CXCR4 (0.52) CXCR4TSHRLMNAMAPTKMT2A
SCHEMBL2189430 0.87 CXCR4 (0.55) CXCR4TSHRNPSR1LMNATP53
SCHEMBL1638006 0.87 CXCR4 (0.60) CXCR4TSHRNPSR1LMNATP53
SCHEMBL2193719 0.81 CXCR4 (0.54) CXCR4ALDH1A1
SCHEMBL2189962 0.80 CXCR4 (0.73) CXCR4TSHRNPSR1LMNATP53
SCHEMBL2191223 0.80 CXCR4 (0.56) CXCR4KMT2APOLBNPC1L3MBTL1
SCHEMBL1637333 0.78 CXCR4 (0.61) CXCR4NPSR1LMNAKMT2AMEN1
SCHEMBL12426518 0.77 CXCR4 (0.49) CXCR4KMT2AMEN1LTA4HPPARG
SCHEMBL1637248 0.74 CXCR4 (0.67) CXCR4KMT2APOLBMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF KUREHA CORPORATION (JP) 2011-07-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF NR0B2, NR5A2, NR1D2 CXCR4 86/4885TSHR 1111/4885NPSR1 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.